Company Search:
Advanced Search
Sponsored Links
Biosynex SA Company Snapshot
Biosynex SA operates within the Diagnostic substances sector. In addition to historical fundamental analyses, the complete report available to purchase compares Biosynex SA with three other pharmaceutical manufacturers in Europe: Les Trois Chenes (2016 sales of 27.34 million Euro [US$33.31 million] ), Diaxonhit SA (27.72 million Euro [US$33.76 million] of which 100% was Genetic R&D), and Horizon Discovery Group PLC which is based in the United Kingdom (£24.07 million [US$33.30 million] of which 53% was Services).

Sales Analysis. Sales increased substantially in 2016: During the year ended December of 2016, sales at Biosynex SA were 27.04 million Euro (US$32.93 million). This is an increase of 173.9% versus 2015, when the company's sales were 9.87 million Euro. This was the fifth consecutive year of sales increases at Biosynex SA (and since 2011, sales have increased a total of 2,474%). Sales of Sale of Goods saw an increase of 255.6% in 2016, from 6.02 million Euro to 21.41 million Euro. Not all segments of Biosynex SA experienced an increase in sales in 2016: sales of Services fell 76.7% to 271,070.00 Euro.
Company ReportsSubscriptions
Looking For More?
Purchace an In-Depth Report
Biosynex SA
  Stock Performance Chart for Biosynex SA
  Stock Data: Recent Stock Performance:
  Current Price (1/19/2018): 3.86
(Figures in Euro)
1 Week 2.9%   13 Weeks 10.6%  
4 Weeks 1.3%   52 Weeks 55.1%  
Biosynex SA Key Data:
  Ticker: ALBIO Country: France
  Exchanges: NYSE Major Industry: Pharmaceuticals & Biotechnology
    Sub Industry: Diagnostic Substances
  2016 Sales 27,035,777
(Year Ending Jan 2017).
Employees: 105
  Currency: Euro Market Cap: 31,208,402
  Fiscal Yr Ends: December Shares Outstanding: 8,085,078
  Share Type: Actions Ordinaires Closely Held Shares:
Sponsored Links
Feedback | Terms and Conditions | Privacy Policy | Site Index
CorporateInformation® website and selected data Copyright © 2000 - by The Winthrop Corporation. All Rights Reserved. Except for quotations by established news media, no pages on this site may be reproduced, stored in a retrieval system, or transmitted for commercial purposes, in any form or by any means, electronic, mechanical, photocopying, recording, or otherwise without prior written permission. Information is believed reliable, but accuracy, completeness and opinions are not guaranteed.